Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,083 | 120 | 99.2% |
| Education | $17.11 | 2 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $786.27 | 47 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $439.80 | 23 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $218.08 | 13 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $163.11 | 8 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $119.51 | 6 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $91.63 | 6 | $0 (2022) |
| Electromed, Inc. | $91.42 | 8 | $0 (2021) |
| JAZZ PHARMACEUTICALS INC. | $46.36 | 2 | $0 (2021) |
| Mylan Specialty L.P. | $45.39 | 2 | $0 (2021) |
| Genentech USA, Inc. | $39.96 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $39.01 | 2 | GlaxoSmithKline, LLC. ($39.01) |
| 2022 | $424.35 | 23 | Novartis Pharmaceuticals Corporation ($119.51) |
| 2021 | $1,637 | 97 | GlaxoSmithKline, LLC. ($683.00) |
All Payment Transactions
122 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/16/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: IMMUNOLOGY | ||||||
| 04/24/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2022 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: RESPIRATORY | ||||||
| 09/22/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: IMMUNOLOGY | ||||||
| 09/15/2022 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: RESPIRATORY | ||||||
| 08/31/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Respiratory | ||||||
| 08/25/2022 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: RESPIRATORY | ||||||
| 07/26/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/08/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/07/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $11.72 | General |
| Category: Respiratory | ||||||
| 05/26/2022 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: RESPIRATORY | ||||||
| 05/20/2022 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: IMMUNOLOGY | ||||||
| 05/19/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.57 | General |
| 05/17/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $30.71 | General |
| Category: RESPIRATORY | ||||||
| 05/05/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Respiratory | ||||||
| 04/26/2022 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: RESPIRATORY | ||||||
| 04/11/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/22/2022 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: RESPIRATORY | ||||||
| 03/09/2022 | Genentech USA, Inc. | Xolair (Biological), Esbriet | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Immunology | ||||||
| 03/03/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: IMMUNOLOGY | ||||||
| 02/17/2022 | Genentech USA, Inc. | Xolair (Biological), Esbriet | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Immunology | ||||||
| 02/09/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: RESPIRATORY | ||||||
| 02/03/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: IMMUNOLOGY | ||||||
| 01/14/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/05/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 113 | 120 | $88,505 | $13,421 |
| 2022 | 2 | 131 | 143 | $98,595 | $18,441 |
| 2021 | 7 | 366 | 398 | $44,141 | $16,533 |
| 2020 | 5 | 405 | 434 | $41,753 | $12,356 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 113 | 120 | $88,505 | $13,421 | 15.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 103 | 115 | $80,755 | $15,193 | 18.8% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 28 | 28 | $17,840 | $3,248 | 18.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 132 | 151 | $15,026 | $6,305 | 42.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 45 | 47 | $7,432 | $2,947 | 39.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 49 | 50 | $4,700 | $2,248 | 47.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 13 | 14 | $9,520 | $2,019 | 21.2% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 72 | 81 | $3,078 | $1,241 | 40.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 14 | 14 | $1,988 | $827.58 | 41.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 13 | 13 | $1,014 | $447.10 | 44.1% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Facility | 2021 | 17 | 17 | $646.00 | $332.78 | 51.5% |
| 94618 | Test for exercise-induced lung stress | Office | 2021 | 11 | 11 | $737.00 | $164.89 | 22.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 139 | 153 | $16,566 | $4,837 | 29.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 91 | 99 | $10,242 | $2,340 | 22.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 34 | 37 | $5,630 | $1,944 | 34.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 23 | 25 | $1,950 | $842.68 | 43.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 20 | 21 | $3,066 | $813.13 | 26.5% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Facility | 2020 | 44 | 44 | $1,672 | $705.85 | 42.2% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 41 | 42 | $1,596 | $665.08 | 41.7% |
| 94618 | Test for exercise-induced lung stress | Office | 2020 | 13 | 13 | $1,031 | $207.77 | 20.2% |
About Jerry Dickess
Jerry Dickess is a Physician Assistant healthcare provider based in Ashland, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2018. The National Provider Identifier (NPI) number assigned to this provider is 1033697990.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jerry Dickess has received a total of $2,101 in payments from pharmaceutical and medical device companies, with $39.01 received in 2023. These payments were reported across 122 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($2,083).
As a Medicare-enrolled provider, Dickess has provided services to 1,015 Medicare beneficiaries, totaling 1,095 services with total Medicare billing of $60,751. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Other Specialties Physician Assistant
- Location Ashland, KY
- Active Since 08/02/2018
- Last Updated 05/24/2022
- Taxonomy Code 363A00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1033697990
Products in Payments
- NUCALA (Biological) $408.79
- TRELEGY ELLIPTA (Drug) $357.98
- BREZTRI (Drug) $253.10
- OFEV (Drug) $163.11
- FASENRA (Biological) $154.57
- GLASSIA (Biological) $131.61
- XOLAIR (Biological) $119.51
- XARELTO (Drug) $91.63
- SMARTVEST (Device) $91.42
- CUVITRU (Biological) $86.47
- DUPIXENT (Biological) $59.07
- SUNOSI (Drug) $46.36
- Yupelri (Drug) $45.39
- Xolair (Biological) $28.88
- ANORO ELLIPTA (Drug) $19.50
- Xofluza (Drug) $11.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Ashland
Sara Everman, Pa-C, PA-C
Physician Assistant — Payments: $9,080
Gregory Moore, Pa-C, PA-C
Physician Assistant — Payments: $4,271
Dustin Adkins, Pa, PA
Physician Assistant — Payments: $3,623
Lindsay Montgomery, Pa-C, PA-C
Physician Assistant — Payments: $3,586
Angela Pannuti, Pa-C, PA-C
Physician Assistant — Payments: $3,068
Deann Brown, Pa-C, Caq-Psych, PA-C, CAQ-PSYCH
Physician Assistant — Payments: $2,989